title: Metastatic apocrine carcinoma of the scalp: prolonged response to systemic chemotherapy.
authors.affiliation: Division of Oncology, Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY, USA.
authors.forename: Kaoutar
authors.initials: K
authors.lastname: Tlemcani
authors.forename: Douglas
authors.initials: D
authors.lastname: Levine
authors.forename: Richard V
authors.initials: RV
authors.lastname: Smith
authors.forename: Margaret
authors.initials: M
authors.lastname: Brandwein-Gensler
authors.forename: David A
authors.initials: DA
authors.lastname: Staffenberg
authors.forename: Madhur K
authors.initials: MK
authors.lastname: Garg
authors.forename: Keivan
authors.initials: K
authors.lastname: Shifteh
authors.forename: Missak
authors.initials: M
authors.lastname: Haigentz
mesh_terms: D000505:Alopecia / Q000150:complications; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D001932:Brain Neoplasms / Q000188:drug therapy / Q000556:secondary; D016190:Carboplatin / Q000008:administration & dosage; D002277:Carcinoma / Q000188:drug therapy* / Q000556:secondary*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000556:secondary; D004334:Drug Administration Schedule; D017809:Fatal Outcome; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008207:Lymphatic Metastasis; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage; D012535:Scalp / Q000473:pathology*; D013544:Sweat Gland Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D055815:Young Adult
chemical_list: D016190:Carboplatin; D017239:Paclitaxel